Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients - 27/06/13
, Nicola Wagner, MD b, ∗, Anja Rabenhorst, MSc a, ∗, Liselotte Pflanz, MD a, Silke Leja, MTA a, Anja Förster, MSc a, Manuela Gehring, MTA c, Alexander Kapp, MD c, Ulrike Raap, MD c| Supported by research grants from the German Research Council (DFG; CRC/SFB832, project A14), the German-Israeli Foundation for Scientific Research and Development (993/2008), and the Wilhelm Sander Foundation (1999.049.2) to (K.H.). |
|
| Disclosure of potential conflict of interest: K. Hartmann has consultant arrangements with Novartis and has received payment for lectures from ALK-Abelló, Novartis, and Shire. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 132 - N° 1
P. 232 - juillet 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
